)
Edge17 Oct 2025
A Castle in the Sky: The Story of Oracle
Oracle's journey from database innovator to disciplined enterprise backbone, now shaping the AI buildout with a standardized cloud infrastructure.
CSPC Pharmaceutical Group (1093) investor relations material
CSPC Pharmaceutical Group H1 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H1 2025 earnings summary22 Aug, 2025
Executive summary
Revenue for H1 2025 was RMB 13,273 million, down 18.5% year-over-year, mainly due to centralised procurement price cuts on key products.
Reported profit attributable to shareholders fell 15.6% to RMB 2,548 million; underlying profit dropped 27.9%.
Interim dividend declared at HK14 cents per share, a 12.5% decrease year-over-year.
Active share buy-backs totaling HK$300 million were completed by June 30, 2025, with 64.3 million shares repurchased and cancelled.
R&D expenses increased 5.5% year-over-year, reflecting continued investment in innovation.
Financial highlights
Gross profit margin decreased by 6.0 percentage points to 65.6%, with gross profit at RMB 8,710 million (down 25.3% YoY).
Basic EPS was RMB 22.29 cents, down 12.6% year-over-year.
Operating cash inflow rose to RMB 3,187 million from RMB 1,425 million in H1 2024.
R&D expenses reached RMB 2,683 million, representing 26.2% of finished drug revenue.
Finished drug revenue declined 24.4% to RMB 10,248 million; bulk products rose 11.9% to RMB 2,075 million; functional food and others increased 8.0% to RMB 951 million.
Outlook and guidance
Focus on innovation and internationalisation, with plans to submit over 50 new drugs or indications for marketing approval by 2028.
Continued expansion of out-licensing and global partnerships to drive recurring revenue.
Multiple innovative drugs in late-stage clinical trials and regulatory submissions planned through 2027.
Plans to strengthen core competitiveness and pursue sustainable, high-quality growth amid industry transformation.
What is the net impact of new products vs. VBP?
Assess the AI platform deal's long-term value.
How does cash flow support capital allocation?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next CSPC Pharmaceutical Group earnings date
Q3 202521 Nov, 2025
Next CSPC Pharmaceutical Group earnings date
Q3 202521 Nov, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Company Research17 Oct 2025
Beneath the Surface: A Conversation with Epiroc CEO Helena Hedblom
Legacy, innovation, and leading one of Sweden's most influential industrial companies into a new era.
)
Investor Relations14 Oct 2025
Boost Your Earnings Season Strategy With Real‑Time Alerts
Quartr Pro provides real time alerts, trend analysis and live coverage, giving analysts and investors instant insights to act faster in earnings.
Frequently asked questions
CSPC Pharmaceutical Group Limited is a China-based pharmaceutical company engaged in the research, development, manufacturing, and distribution of pharmaceutical products. The company operates through multiple segments, including finished drugs, bulk drug manufacturing, and innovative drug development. Its product portfolio spans a range of therapeutic areas such as cardiovascular, oncology, anti-infectives, and central nervous system disorders. The company is headquartered in Shijiazhuang, China, and its shares are listed on the HKEX.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage